Similar Search Results

Inattention and Switching Costs as Sources of Inertia in Medicare Part D

Heiss, Florian - 2016

The trend towards giving consumers choice about their health plans has invited research on how good they actually are at making these decisions. The introduction of Medicare Part D is an important example. Initial plan choices in this market were generally far from optimal. In this paper, we...

Persistent link: https://www.econbiz.de/10012455915

Patient Responses to Incentives in Consumer-directed Health Plans : Evidence from Pharmaceuticals

Huckfeldt, Peter J. - 2015

deductible, while in the second firm pharmaceuticals were exempt. Employees in the first firm shifted the timing of drug … use of pharmaceuticals for chronic diseases. We compare two large firms where nearly all employees were switched to CDHPs … to firms with conventional health insurance plans. In the first firm's CDHP, pharmaceuticals were subject to the …

Persistent link: https://www.econbiz.de/10012457739

Does Consolidation in Insurer Markets affect Insurance Enrollment and Drug Expenditures? : Evidence from Medicare Part D

Chatterji, Pinka; Ho, Chun-Yu; Jin, Tao; Wang, Yichuan - National Bureau of Economic Research - 2024

Since the inception of Medicare Part D in 2006, mergers and acquisitions (M&A) and regulatory changes have led to increased concentration and reduced plan variety in the standalone prescription drug plan (PDP) portion of the market. We examine how this industry consolidation affects Medicare...

Persistent link: https://www.econbiz.de/10014512121

How Does Cost-Sharing Affect Drug Purchases? Insurance Regimes in the Private Market for Prescription Drugs

Dor, Avi - 2004

Insurance for prescription drugs is characterized by two types of cost-sharing: flat copayments and variable coinsurance. We develop a theoretical model to show that refill purchases of preventive drugs (compliance) are lower under coinsurance due to the consumer's exposure to variation in drug...

Persistent link: https://www.econbiz.de/10012467952

Private Provision of Social Insurance : Drug-specific Price Elasticities and Cost Sharing in Medicare Part D

Einav, Liran - 2016

Standard theory suggests that optimal consumer cost-sharing in health insurance increases with the price elasticity of demand, yet publicly-provided drug coverage typically involves uniform cost-sharing across drugs. We investigate how private drug plans set cost-sharing in the context of...

Persistent link: https://www.econbiz.de/10012456398

Exit, Voice or Loyalty? An Investigation into Mandated Portability of Front-Loaded Private Health Plans

Atal, Juan Pablo - 2017

We study theoretically and empirically how consumers in an individual private long-term health insurance market with front-loaded contracts respond to newly mandated portability requirements of their old-age provisions. To foster competition, effective 2009, German legislature made the...

Persistent link: https://www.econbiz.de/10012455213

What Do Longitudinal Data on Millions of Hospital Visits Tell us About The Value of Public Health Insurance as a Safety Net for the Young and Privately Insured?

Kowalski, Amanda E. - 2015

Young people with private health insurance sometimes transition to the public health insurance safety net after they get sick, but popular sources of cross-sectional data obscure how frequently these transitions occur. We use longitudinal data on almost all hospital visits in New York from 1995...

Persistent link: https://www.econbiz.de/10012457779

Patient Costs and Physicians' Information

Dickstein, Michael J.; Jeon, Jihye; Morales, Eduardo - National Bureau of Economic Research - 2024

Health insurance plans in the U.S. increasingly use price mechanisms to steer demand for prescription drugs. The effectiveness of these incentives, however, depends both on physicians' price sensitivity and their knowledge of patient prices. We develop a moment inequality model that allows...

Persistent link: https://www.econbiz.de/10014468214

The Effect of Patient Cost Sharing on Utilization, Health, and Risk Protection

Shigeoka, Hitoshi - 2013

This paper exploits a sharp reduction in patient cost sharing at age 70 in Japan, using a regression discontinuity design to examine its effect on utilization, health, and financial risk arising from out-of-pocket expenditures. Due to the national policy, cost sharing is 60-80 percent lower at...

Persistent link: https://www.econbiz.de/10012458937

The Value of Employer-Sponsored Health Insurance

Mulligan, Casey B. - National Bureau of Economic Research - 2021

Based on published estimates of its price elasticity of demand and of tax wedges, as well as the method of revealed preference, I estimate that the annual social value of ESI is about $1.5 trillion beyond what policyholders, their employers, and taxpayers pay for it. The private component of...

Persistent link: https://www.econbiz.de/10012496144

1
2
3
4
5
6
7
8
9
10
Next
Last